7Baggers

Processa Pharmaceuticals Inc
(NASDAQ:PCSA) 

PCSA stock logo

Processa Pharmaceuticals is committed to developing drug products aimed at improving the quality of life for patients with unmet medical needs.

Founded: 2011
CEO: David Young  
Sector: Pharmaceuticals
Industry: PHARMACEUTICAL PREPARATIONS
Pharmaceuticals
Share this website to your friends
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
    Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 
                                                     
      operating expenses
    		                                                 
      research and development expenses
    		2,113,646 1,661,646 2,447,286 1,588,540   1,730,444 1,539,070   1,688,164 1,627,480 3,136,838 3,137,292 2,043,984 2,071,176 1,722,364 1,614,954 1,476,160 1,710,969 532,587 427,109 501,771 516,404 584,979 726,904                        
      general and administrative expenses
    		1,588,243 1,827,197 1,503,497 1,258,450   1,351,580 1,270,528   1,026,301 2,478,055 2,920,280 2,034,456 1,184,730 1,297,834 1,338,113 1,329,213 717,147 1,982,235 422,958 374,878 484,353 395,580 419,028 410,072    350,581 483,955                   
      operating income
    		-3,701,889 -3,488,843 -3,950,783 -2,846,990 -2,734,731 -3,424,853 -3,082,024 -2,809,598 -2,469,450 -2,167,612 -2,714,465 -4,105,535 -6,057,118 -5,171,748 -3,228,714 -3,369,010 -3,111,430 -3,459,797 -2,193,307 -10,393,204 -2,955,545 -801,987 -986,124 -911,984 -1,004,007 -1,136,976 -882,516 -741,948 -1,062,971 -1,428,224 -1,291,616                   
      yoy
    		35.37% 1.87% 28.19% 1.33% 10.74% 58.00% 13.54% -31.57% -59.23% -58.09% -15.93% 21.86% 94.67% 49.48% 47.21% -67.58% 5.27% 331.40% 122.42% 1039.63% 194.37% -29.46% 11.74% 22.92% -5.55% -20.39% -31.67%                       
      qoq
    		6.11% -11.69% 38.77% 4.10% -20.15% 11.12% 9.70% 13.77% 13.92% -20.15% -33.88% -32.22% 17.12% 60.18% -4.16% 8.28% -10.07% 57.74% -78.90% 251.65% 268.53% -18.67% 8.13% -9.17% -11.69% 28.83% 18.95% -30.20% -25.57% 10.58%                    
      operating margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% NaN% NaN% NaN% NaN% NaN% NaN% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 
      other income
    		-61,720 52,270 16,865 12,585   71,698 83,217   101,900 83,462        -55,450.25 -186,197                             
      net income
    		-3,358,938 -3,436,573 -3,933,918 -2,834,405 -2,728,708 -3,384,703 -3,010,326 -2,726,381 -2,404,931 -2,081,951 -2,612,565 -4,022,073 -6,020,410 -5,164,368 -3,227,131 -3,183,794 -2,987,217 -3,157,043 -2,099,481 -9,734,753 -3,071,285 -733,414 -874,336 -774,443 -863,524 -969,078 -750,832 -609,173 -852,822 -1,206,074 -1,096,798 -204,413 -42,851 -75,627 -90,824 -68,333 -43,200 -133,625 -362,766 -295,743 -2,051,108 -644,606 -1,538,802 -791,954 -851,216 -1,344,276 -806,925 -718,840 -726,571 
      yoy
    		23.10% 1.53% 30.68% 3.96% 13.46% 62.57% 15.22% -32.21% -60.05% -59.69% -19.04% 26.33% 101.54% 63.58% 53.71% -67.29% -2.74% 330.46% 140.12% 1157.00% 255.67% -24.32% 16.45% 27.13% 1.25% -19.65% -31.54% 198.01% 1890.20% 1494.77% 1107.61% 199.14% -0.81% -43.40% -74.96% -76.89% -97.89% -79.27% -76.43% -62.66% 140.96% -52.05% 90.70% 10.17% 17.16%     
      qoq
    		-2.26% -12.64% 38.79% 3.87% -19.38% 12.44% 10.41% 13.37% 15.51% -20.31% -35.04% -33.19% 16.58% 60.03% 1.36% 6.58% -5.38% 50.37% -78.43% 216.96% 318.77% -16.12% 12.90% -10.32% -10.89% 29.07% 23.25% -28.57% -29.29% 9.96% 436.56% 377.03% -43.34% -16.73% 32.91% 58.18% -67.67% -63.16% 22.66% -85.58% 218.20% -58.11% 94.30% -6.96% -36.68% 66.59% 12.25% -1.06%  
      net income margin %
    		-Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -Infinity% -2672.50% 3190.55% -508.46% -10235.07% -1383.57% -10686.13% -1505.02% -754.39% -6607.40% -1151.27% -570.92% -746.89% 
      net loss per common share - basic and diluted
    		-9.95 -0.07 -0.25 -0.3 -0.74 -1.03 -1.01 -1.11 -8.14 -0.08 -0.1 -0.18 -0.37 -0.32 -0.2 -0.21 -0.19 -0.2 -0.14 -1.7 -0.55 -0.13 -0.16 -0.63 -0.02 -0.03 -0.02 -0.01 -0.02 -0.03 -0.03                   
      weighted-average common shares used to compute net loss applicable to common shares - basic and diluted
    		 47,525,522 15,569,312   3,275,998 2,983,283    26,935,463  16,200,222 15,940,510   15,531,442 15,406,363   5,594,370    38,798,251 38,674,265    36,623,697                    
      weighted average common shares used to compute net loss per common shares - basic and diluted
    		   9,526,796                   5,515,447                           
      research and development
    		    1,389,173.5 2,287,525   1,119,698.25 1,151,740                 484,750 607,836 611,612    83 83 287 574 5,697  2,100 1,714 10,982 14,450 9,752 11,729 68,495 99,769 76,611 55,465 63,360 
      general and administrative
    		    939,945.25 1,137,328   1,127,204.5 1,015,872                 397,766 134,112 451,359                     
      interest income
    		    6,023 40,150   64,519 85,661   36,708 7,380 1,583 3,464 1,771 1,814 4,940   18 829 662 1,503 3,398 5,985 8,134 6,457 2,681 1,024         850 2,549 1,252 174 1 2 72 371 989 393 
      net operating loss before income tax benefit
    		      -3,010,326    -2,612,565 -4,022,073 -6,020,410 -5,164,368 -3,227,131 -3,365,546 -3,109,659 -3,294,212 -2,188,729 -10,449,351 -3,141,742 -821,249 -1,002,465 -935,007 -1,004,775 -1,139,680 -881,131 -740,642 -1,064,837  -1,378,332                   
      income tax benefit
    		               181,752 122,442 137,169 89,248 714,598 70,457 87,835 128,129 160,564 141,251 170,602 130,299 131,469 212,015 277,783 281,534                   
      weighted-average common shares used to compute net loss per common shares - basic and diluted
    		       2,466,523    22,770,789   15,831,118    14,583,698        38,674,265 37,324,267                      
      weighted average common shares used to compute net loss applicable to common shares - basic and diluted
    		         27,002,908            5,515,447         35,272,626                   
      acquisition of in-process research and development
    		                50,953 515,630  6,700,000 2,000,000                             
      forgiveness of ppp loan and related accrued interest
    		               40,942.75  163,771                                
      interest expense
    		                  -362   -19,280 -17,170 -23,685 -2,271 -6,102 -4,600 -6,828 -8,323 -58,314 -87,740 -44,158 -63,410 -61,945 -45,515.5 -63,322 -62,634 -56,106 -42,049.5 -61,975 -59,412 -46,811 -62,789 -130,135 -112,935 -60,096 -14,683 -45,399 -33,754 
      total operating expenses
    		                   1,185,913.75 2,955,545 801,987  755,874.5 1,004,007 1,136,976  945,748 1,062,971 1,428,224 1,291,616                   
      total other income
    		                     -19,262  -521.75 -768 -2,704  -36,053.5 -1,866 -55,633 -86,716                   
      operating expenses:
    		                                                 
      other income:
    		                                                 
      weighted-average common shares used to compute
    		                                                 
      net loss applicable to common shares - basic and diluted
    		                           9,217,330.75 38,674,265                     
      research and development costs
    		                             1,077,643 807,661                   
      net loss before income tax benefit
    		                             -1,483,857                    
      revenue:
    		                                                 
      equipment sales
    		                                     5,000 24,246 17,593  32,760 50 16,624 77,000 7,445 44,535 118,728 96,000 
      other revenue
    		                                      -6,746 40,572  5,000 1,260  4,860  25,555 7,182 1,280 
      total revenues
    		                                     5,000 -11,370 58,165 20,040 46,590 14,400 52,621 112,835 20,345 70,090 125,910 97,280 
      yoy
    		                                     -89.27% -178.96% 10.54% -82.24% 129.00% -79.45% -58.21% 15.99%     
      qoq
    		                                     -143.98% -119.55% 190.24% -56.99% 223.54% -72.63% -53.36% 454.61% -70.97% -44.33% 29.43%  
      cost of goods sold
    		                                      42,982 42,618 11,007 29,269 8,630 25,289 70,192 9,140 33,902 80,450 61,525 
      gross profit
    		                                     5,000 -54,352 15,547 9,033 17,321 5,770 27,332 42,643 11,205 36,188 45,460 35,755 
      yoy
    		                                     -71.13% -1041.98% -43.12% -78.82% 54.58% -84.06% -39.88% 19.26%     
      qoq
    		                                     -109.20% -449.60% 72.11% -47.85% 200.19% -78.89% -35.91% 280.57% -69.04% -20.40% 27.14%  
      gross margin %
    		NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% NaN% 100.00% 478.03% 26.73% 45.07% 37.18% 40.07% 51.94% 37.79% 55.07% 51.63% 36.11% 36.75% 
      expenses:
    		                                                 
      selling, general and administrative
    		                               163,771 10,270 13,599 -18,226 4,395 3,284 80,515 -242,771 119,299 467,035 601,893 649,975 677,398 712,406 805,004 752,140 664,425 665,605 
      total expenses
    		                               163,771 10,353 13,682 -17,939 4,969 8,981 80,515 -139,602 206,012 1,995,876 616,343 1,481,932 689,127 780,901 1,295,432 828,751 719,890 728,965 
      income from operations
    		                               -163,771 -10,353 -13,682 -22,366.25 -4,969 -8,981 -75,515 -694,083.5 -190,465 -1,986,843 -599,022 -1,476,162 -661,795 -738,258 -1,284,227 -792,563 -674,430 -693,210 
      other income and expense:
    		                                                 
      gain on debt forgiveness
    		                               5,447 30,912  6,288.75  25,155             
      total other income and expense
    		                               -38,711 -32,498 -61,945 -108,746 -63,322 -37,479 -56,106 -76,684 -105,253 -64,240 -45,559 -62,615 -130,134 -112,933 -60,024 -14,312 -44,410 -33,361 
      income before income taxes
    		                               -202,482 -42,851 -75,627 -90,807 -68,291 -46,460 -131,621 8,566 -295,718 -2,051,083 -644,581 -1,538,777 -791,929 -851,191 -1,344,251 -806,875 -718,840 -726,571 
      income taxes
    		                               -1,931       -25 -25 -25 -25 -25 -25 -25 -25    
      loss from continued operations, net of tax
    		                               -204,413 -42,851 -75,627 -90,807 -68,291 -46,460 -131,621            
      income from discontinued operations, net of tax
    		                                  303.5 -42 3,260             
      preferred stock cumulative dividend and deemed dividend
    		                                -10,706 -10,588 -10,824 -10,824 -10,706 -10,705            
      net loss applicable to common stockholders
    		                               -204,413 -53,557 -86,215 -101,648 -79,157 -53,906 -144,330 -373,589 -306,567 -2,061,814 -655,195        
      net loss per common share basic and diluted from continuing operations
    		                               -0.02  -0.01  -0.01 -0.01 -0.01            
      net loss per common share basic and diluted from discontinued operations
    		                                                 
      net loss per common share basic and diluted
    		                               -0.02  -0.01 -0.01 -0.01 -0.01 -0.01 -0.04 -0.03 -0.19 -0.06 -0.31 -0.1 -0.11 -0.17 0.01 -0.12 -0.34 
      weighted-average shares outstanding used in calculating net loss per common share
    		                               11,158,191 11,017,388 11,017,388 11,017,388 11,017,388 11,017,388 11,017,640 11,012,565 11,017,640 11,017,640 10,997,056 8,857,815 8,433,752 8,397,442 8,264,992 5,037,405 7,837,262 2,233,414 
      loss from discontinued operations, net of tax
    		                                     -2,004            
      impairment of assets held for sale
    		                                      101,069 84,999          
      impairment of intangible asset
    		                                        1,517,859         
      loss on disposal of assets
    		                                      -9,238 -44,128 -7,377         
      service revenue
    		                                      7,217.5  20,040 8,830 13,090 35,997 30,975 12,900    
      impairment on goodwill
    		                                                 
      preferred stock cumulative dividend
    		                                      8,029.75 10,824 10,706 10,589 28,052 53,054 61,135 38,548 59,649 213,760 41,787 
      impairment of goodwill
    		                                          97,664.75   390,659    
      deemed dividend
    		                                          6,708 26,832      
      net loss attributable to common stockholders
    		                                          -781,622 -871,840 -912,351 -1,382,824 -625,093 -932,600  
      net loss available to common stockholders
    		                                                -768,358 
    Balance Sheets:
    Quarterly
    Annual
      Unit: USD2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 2013-06-30 
                                          
        assets
      		                                    
        current assets
      		                                    
        cash and cash equivalents
      		5,536,955 6,308,420 6,936,620 2,897,072 1,191,325 2,891,464 5,571,120 8,920,363 4,706,197 6,860,672 8,677,133 10,741,602 9,054,576 12,064,142 14,394,655 16,497,581 19,093,188 20,831,195 80,262 1,949 1,639 3,237 6,692 14,914 2,439 2,090 15,097 15,193 41,783 21,234 55,734 39,899 82,248 186,864 1,001,937 629,804 
        prepaid expenses and other
      		133,919 278,342 217,201 860,814 682,294 1,946,675 1,906,854 857,635 926,300 1,046,790 1,220,150 1,477,519 1,832,109 1,896,633 1,989,466 1,759,296 1,506,603 1,664,257                   
        total current assets
      		5,670,874 6,586,762 7,153,821 3,757,886 1,873,619 4,838,139 7,477,974 9,800,293 5,632,497 7,907,462 9,897,283 12,219,121 10,886,685 13,960,775 16,384,121 18,327,151 20,670,065 22,565,726 80,262 1,949 1,639 3,237 35,234 43,498 47,340 104,162 322,627 479,195 497,152 379,209 400,570 466,028 478,307 514,706 1,313,429 937,790 
        digital assets at fair value
      		1,145,180                                    
        prepaid expenses
      		993,701 993,701 993,701 993,701 1,274,442                                
        equipment
      		3,812                                    
        operating lease right-of-use assets
      		   47,737 70,677    146,057 167,035 187,605     74,181                     
        total assets
      		7,813,567 7,584,576 8,181,789 4,809,574 3,229,289 4,942,152 7,600,976 9,944,732 5,786,643 8,082,726 10,090,423 12,432,443 18,604,465 21,657,590 24,300,792 26,463,505 29,025,295 31,137,959 80,262 1,949 1,639 3,237 35,234 43,498 47,340 104,321 498,144 877,714 2,543,020 2,542,052 2,666,677 2,784,698 2,907,620 2,938,053 3,843,050 3,467,367 
        liabilities and stockholders’ equity
      		                                    
        current liabilities
      		                                    
        current maturities of lease liability
      		  25,584 49,659 73,020                                
        accounts payable
      		1,056,796 727,172 785,754 552,560 880,880 711,710 953,086 455,368 311,617 346,299 239,022 316,709 311,066 648,104 316,092 218,905 354,977 287,878 95,568 91,187 179,322 166,165 170,659 173,913 169,270 159,249 190,726 218,791 177,653 190,168 144,558 111,962 82,688 77,028 101,394 233,281 
        accrued expenses
      		1,179,457 1,023,806 1,263,243 680,747 578,731 412,813 505,397 465,618 146,274 202,236 311,502 1,573,961 216,407 307,412 292,566 279,265 378,660 369,110                   
        total current liabilities
      		2,236,253 1,750,978 2,074,581 1,282,966 1,532,631 1,219,199 1,551,664 1,010,666 730,579 826,070 821,414 2,160,836 1,192,733 1,571,068 1,057,779 971,020 1,226,406 1,161,177 115,314 2,492,877 2,439,010 2,354,393 2,284,742 2,213,850 2,165,415 2,083,128 2,088,606 2,093,265 1,721,784 840,053 809,470 561,726 784,502 1,121,717 1,309,822 2,364,906 
        non-current lease liability
      		    487                                
        total liabilities
      		2,236,253 1,750,978 2,074,581 1,282,966 1,533,118 1,221,367 1,577,312 1,061,366 797,484 914,847 930,741 2,290,194 1,364,440 1,575,723 1,063,926 978,405 1,816,931 1,896,267 115,314 2,492,877 2,439,010 2,354,393 2,284,742 2,213,850 2,165,415 2,083,128 2,116,113 2,198,213 1,841,230 1,334,119 2,783,444 2,161,710 1,878,005 1,267,175 1,466,020 2,457,184 
        commitments and contingencies
      		                                    
        stockholders’ equity
      		                                    
        preferred stock, par value 0.0001...
      		                                    
        common stock, par value 0.0001...
      		257 5,287 4,029 527 371 327 287 286 129 2,473 2,463 2,463 1,600 1,592 1,593 1,571 1,560 1,560                   
        additional paid-in capital
      		106,660,090 103,552,406 100,390,701 93,879,685 89,214,999 88,510,949 87,429,165 87,278,542 80,658,111 80,429,556 80,339,418 78,709,420 68,773,666 65,595,106 63,585,736 62,306,861 60,846,342 59,892,453 16,998,820 14,329,057 14,329,057 14,329,057 14,329,057 14,329,057 14,327,428 14,322,366 14,309,615 14,300,514 14,260,989 14,111,944 9,884,774 9,752,689 9,247,645 8,483,727 8,334,863 6,041,995 
        treasury stock
      		-300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000 -300,000                      
        accumulated deficit
      		-100,783,033 -97,424,095 -93,987,522 -90,053,604 -87,219,199 -84,490,491 -81,105,788 -78,095,462 -75,369,081 -72,964,150 -70,882,199 -68,269,634 -51,235,241 -45,214,831 -40,050,463 -36,823,332 -33,639,538 -30,652,321 -17,036,341 -15,394,689 -15,341,132 -15,254,917 -15,153,286 -15,074,172 -15,017,006 -14,874,680 -15,928,704    -10,002,472 -9,130,633     
        total stockholders’ equity
      		5,577,314 5,833,598 6,107,208 3,526,608 1,696,171 3,720,785 6,023,664 8,883,366 4,989,159 7,167,879 9,159,682 10,142,249 17,240,025 20,081,867 23,236,866 25,485,100 27,208,364 29,241,692    -2,351,156    -1,978,807 -1,617,969 -1,320,499 701,790 1,207,933 -116,767 622,988 1,029,615 1,670,878 2,377,030 1,010,183 
        total liabilities and stockholders’ equity
      		7,813,567 7,584,576 8,181,789 4,809,574 3,229,289 4,942,152 7,600,976 9,944,732 5,786,643 8,082,726 10,090,423 12,432,443 18,604,465 21,657,590 24,300,792 26,463,505 29,025,295 31,137,959    3,237    104,321 498,144 877,714 2,543,020 2,542,052 2,666,677 2,784,698 2,907,620 2,938,053 3,843,050 3,467,367 
        non-current assets
      		                                    
        property and equipment
      		 4,113 4,414 4,715 5,016 5,317 2,276 2,415 2,554 2,694                           
        right-of-use assets
      		  24,318                                  
        non-current liabilities
      		                                    
        total non-current assets
      		  993,701 993,701 1,274,442                                
        other assets
      		                                    
        other
      		  5,535 5,535 5,535    5,535                            
        total other assets
      		  29,853 53,272 76,212 98,696 120,726 142,024 151,592 172,570 193,140 213,322 7,717,780 7,696,815 7,916,671 8,136,354 8,355,230 8,572,233                   
        due to licensor
      		        189,000 189,000 189,000 189,000 589,000 589,000 400,000 400,000 400,000 400,000                   
        due to related parties
      		        39 5,791      1,772  11,742                   
        lease right-of-use assets, net of accumulated amortization
      		     93,161 115,191 136,489                             
        security deposit
      		     5,535 5,535 5,535  5,535 5,535 5,535 5,535 5,535 5,535 5,535 5,535 5,535                   
        current maturities of lease liabilities
      		     94,676 93,181 89,680                             
        non-current lease liabilities
      		     2,168 25,648 50,700                             
        due from related parties
      		       22,295                             
        current maturities of operating lease liability
      		        83,649 82,744 81,890 81,166 76,260 26,552 49,121 71,078 92,769 92,447                   
        non-current operating lease liability
      		        66,905 88,777 109,327 129,358 171,707 4,655 6,147 7,385 8,773 30,896                   
        operating lease right-of-use assets, net of accumulated amortization
      		           207,787 246,979 28,890 51,622  95,934 117,236                   
        due from tax agencies
      		               70,274 70,274 70,274                   
        intangible assets, net of accumulated amortization
      		            7,465,266 7,662,390 7,859,514  8,253,761 8,449,462                   
        due from related party
      		                                    
        software
      		               19,740                     
        office equipment
      		               9,327                     
        total cost
      		               29,067                     
        less: accumulated depreciation
      		               29,067                     
        intangible assets
      		               8,056,638                     
        note payable – paycheck protection program, current portion
      		                                    
        accrued interest
      		                                    
        note payable – paycheck protection program
      		                                    
        non-current due to licensor
      		                400,000 400,000                   
        net deferred tax liability
      		                181,752 304,194                   
        current assets:
      		                                    
        liabilities and stockholders’ deficit
      		                                    
        current liabilities:
      		                                    
        accrued liabilities
      		                  19,746 147,619 144,027 134,513 123,689 112,865 93,859 95,339 101,140 72,462 80,838 105,613 130,165 155,474 160,242 256,094 165,384 111,279 
        interest payable
      		                   139,075 123,758 108,608 93,123 77,638 212,506 161,608 104,150 51,161 28,418 19,541    1,812 2,630 2,630 
        interest payable, related party
      		                   427,455 379,362 332,566 284,730 236,893             
        income taxes payable
      		                   200 200 200 200 200 200 200 175 150 125 100    100 75 50 
        senior secured notes payable, related party
      		                      962,361 962,361             
        unsecured notes payable
      		                              1,824,561 1,246,335 728,908    
        revolving line of credit
      		                   91,980 91,980 91,980 91,980 91,980   229,980 229,980 229,980 229,980 229,980 229,980 229,980    
        revolving line of credit, related party
      		                   138,000 138,000 138,000 138,000 138,000             
        stockholders’ deficit:
      		                                    
        series d preferred stock, 0.0001 par value...
      		                   18 18 18 18 18 18 18 18 18 18 18 88 89 78 73 73  
        common stock, 0.0001 par value...
      		                  2,469 1,102 1,102 1,102 1,102 1,102 1,102 1,102 1,102 1,102 1,102 1,095 843 843 827 808 805 703 
        total stockholders’ deficit
      		                  -35,052 -2,490,928 -2,437,371  -2,249,508 -2,170,352 -2,118,075            
        total liabilities and stockholders’ deficit
      		                  80,262 1,949 1,639  35,234 43,498 47,340            
        current portion of senior secured notes payable, related party
      		                   1,037,361 962,361 962,361               
        current portion of unsecured notes payable
      		                   420,000 420,000         20,000    90,000   
        stockholder’s deficit from discontinued operations
      		                   -1,426,416 -1,426,416  -1,426,399 -1,426,357 -1,429,617            
        prepaid expenses and other current assets
      		                        1,269 47,722 5,970 32,501 42,428 131,862 117,346 120,822 111,934 80,386 80,092 48,460 
        assets held for sale
      		                        15,000 42,000 109,500          
        current assets from discontinued operations
      		                      3,542 3,584 3,632 12,350           
        equipment, net of depreciation
      		                         159 175,517 398,519 438,723 466,413 480,391 443,668 465,026 369,775 386,763 297,433 
        current portion of unsecured notes payable, net of discount of 0 and 967 at december 31, 2016 and 2015, respectively
      		                     420,000               
        current liabilities from discontinued operations
      		                        307,219 300,338           
        stockholders’ equity (deficit) from discontinued operations
      		                     -1,426,416    -1,427,613           
        other receivables
      		                      25,000 25,000 25,000            
        unsecured notes payable, net of discount of 0 and 967 at september 30, 2016 and december 31, 2015, respectively
      		                      420,000              
        unsecured notes payable, net of discount of 0 and 967 at june 30, 2016 and december 31, 2015, respectively
      		                       420,000             
        senior secured notes payable
      		                        962,361  947,361 908,361 630,000        
        unsecured notes payable, net of discount of 967 at december 31, 2015
      		                        420,000            
        accounts receivable
      		                          11,613 15,060 5,150 4,095 26,739 99,030 20,345 19,200 24,399 61,154 
        inventory
      		                          141,484 203,230 197,129 222,018 200,751 206,277 263,780 228,256 207,001 198,372 
        intangible assets, net of amortization
      		                            1,607,145 1,696,430 1,785,716 1,875,002 1,964,287 2,053,572 2,142,858 2,232,144 
        other assets, from discontinued operations
      		                                    
        deferred revenue
      		                          22,500 165,629 143,129 58,165       
        loan payable
      		                           57,340 56,910 56,486 54,767 44,290 41,572 41,186 40,339 27,579 
        current portion of senior secured notes payable
      		                         947,361    160,000      990,087 
        current portion of unsecured notes payable, net of discount of 967 at december 31, 2015
      		                         419,033           
        long-term liabilities:
      		                                    
        unsecured notes payable, net of discount of 59,768 at december 31, 2014
      		                                    
        total long-term liabilities
      		                          27,507 104,948 119,446 494,066 1,973,974 1,599,984 1,093,503 145,458 156,198 92,278 
        consigned inventory
      		                          38,963 124,448 124,448        
        liability related to assets held for sale
      		                          43,549          
        equipment loan payable
      		                          44,813          
        unsecured notes payable, net of discount of 15,788 at september 30, 2015
      		                          404,212          
        note receivable
      		                           88,763 86,214        
        unsecured notes payable, net of discount of 30,609 at june 30, 2015
      		                           389,391         
        stockholders’ equity:
      		                                    
        accumulated deficit during development stage
      		                           -15,622,133 -13,560,319 -12,905,124   -8,218,950 -6,813,758 -5,958,742 -5,032,622 
        unsecured notes payable, net of discount of 45,269 at march 31, 2015
      		                            374,731        
        advance payment
      		                                 155,497   
        current portion of senior subordinated note payable
      		                                 500,000 1,000,000 1,000,000 
        unsecured notes payable, net of discount of 59,768
      		                             360,232       
        series b preferred stock, 0.0001 par value...
      		                                10 18 21 70 
        series c preferred stock, 0.0001 par value...
      		                                5 10 10 33 
        current portion of notes payable
      		                              250,000 250,000 500,000    
        senior subordinated note payable
      		                                    
        series a preferred stock, 0.0001 par value...
      		                                   4 
      Cashflow Statements:
      Quarterly
      Annual
        Unit: USD2025-12-31 2024-12-31 2023-12-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2017-09-30 2017-06-30 2017-03-31 2016-12-31 2016-09-30 2016-06-30 2016-03-31 2015-12-31 2015-09-30 2015-06-30 2015-03-31 2014-12-31 2014-09-30 2014-06-30 2014-03-31 2013-12-31 2013-09-30 
                                  
          cash flows from operating activities
        		                          
          net loss
        		-3,358,938 -2,728,708 -2,404,931 -774,443 -863,523 -969,078 -750,832 -609,173 -853,004 -322,891 -118,478 -75,627 -90,824 -68,333 -43,200 -133,625 -362,766 -295,746 -2,051,109 -644,606 -1,538,802 -791,953 -851,219 -1,344,276 -806,925 -718,840 
          adjustments to reconcile net loss to net cash from operating activities:
        		                          
          depreciation
        		301 301 140 2,111 2,111 2,112 2,111 2,111 2,111             22,427 23,358 21,775  14,518 
          non-cash lease expense for right-of-use assets
        		0 22,484                         
          unrealized gain on digital assets at fair value
        		                          
          stock-based compensation
        		123,541 155,048 256,818 116,314 269,129 66,476 58,559 23,535     0 0 1,629 5,062 12,751 9,101 39,525 35,552 21,670    148,864 17,526 
          net changes in operating assets and liabilities:
        		                          
          prepaid expenses and other
        		144,423 -10,061 120,490      -198,805                  
          operating lease liability
        		0 -21,873 -20,967 -18,780 -20,059 -342,101 303,161                    
          accounts payable
        		329,624 169,170 -34,682 10,751 -78,490 -139,706 -9,045 212,082 -171,379                  
          due from related parties
        		        -39,270                  
          accrued expenses
        		155,651 165,918 -55,962 89,569 -178,605 174,055 34,924                    
          net cash from operating activities
        		-2,900,578 -2,247,721 -2,123,868 -1,513,486 -217,683 -526,547 -492,429 -463,976 -1,010,752                  
          capital expenditures
        		0 0 0 0 0 0 0 0 0                  
          free cash flows
        		-2,900,578 -2,247,721 -2,123,868 -1,513,486 -217,683 -526,547 -492,429 -463,976 -1,010,752                  
          cash flows from investing activities
        		                          
          purchase of digital asset
        		                          
          purchase of equipment
        		                          
          net cash from investing activities
        		 0 0     0 475,500                  
          cash flows from financing activities
        		                          
          net proceeds from issuance of common stock
        		        109,022                  
          shares withheld to pay taxes on stock-based compensation
        		0 -312                         
          settlement of stock award
        		 0 0                        
          payment of finance lease obligation
        		0 -1,464                         
          net cash from financing activities
        		2,979,113 547,582 -30,607     -219,286 109,022                  
          net increase in cash and cash equivalents
        		-771,465   187,234 -217,683                      
          cash and cash equivalents - beginning of year
        		                          
          cash and cash equivalents - end of year
        		                          
          net proceeds from the sale of stock and exercise of warrants
        		                          
          cash and cash equivalents - beginning of period
        		                          
          cash and cash equivalents - end of period
        		                          
          supplemental cash flow information:
        		                          
          cash paid for interest
        		                          
          cash paid for income taxes
        		                          
          non-cash financing activities
        		                          
          issuance of 5,000 shares of common stock in connection with a licensing agreement which had previously been recorded as a due to licensor
        		                          
          new right-of-use asset
        		                          
          financing lease liability
        		                          
          net
        		                          
          warrants issued for consulting services
        		                          
          purchase of property and equipment
        		 0 0                        
          net proceeds from issuance of stock
        		                          
          net decrease in cash and cash equivalents
        		        -426,230                  
          warrants issued to purchase 158,007 shares of common stock in connection with a consulting agreement
        		                          
          due (from) to related parties
        		  -5,752    -25,582                    
          net proceeds from common stock issued
        		                          
          net increase in cash
        		                          
          cash and cash equivalents – beginning of period
        		    0 0 1,740,961                    
          cash and cash equivalents – end of period
        		    -217,683 -526,547 1,248,532                    
          issuance of common stock in satisfaction of a due to licensor in connection with a licensing agreement
        		                          
          right-of-use asset obtained in exchange for financing lease liability
        		                          
          non-cash milestone expense in connection with license agreement
        		                          
          amortization of debt issuance costs
        		       2,228 3,709                  
          amortization of intangible asset
        		   198,832 198,832 198,832 198,832 198,833 200,255             89,286 89,285 89,285   
          impairment of intangible asset
        		                0 0         
          warrants issued to purchase 158,007 shares of common stock
        		                          
          other receivables
        		                          
          acquisition of treasury stock
        		                          
          lease expense for right-of-use assets
        		                          
          milestone expense in connection with license agreement
        		                          
          amortization of issuance costs
        		                          
          warrants issued to purchase 3,160,130 shares of common stock in connection with a consulting agreement
        		                          
          issuance of 123,609 shares of common stock in connection with the purchase agreement with lincoln park
        		                          
          right-of-use asset obtained in exchange for operating lease liability
        		      -293,198                    
          deferred income tax expense
        		        -212,015                  
          accrued interest
        		   21,902 0 3,987 4,600 4,600 4,600                  
          purchase of software license
        		                          
          purchase of intangible asset
        		                          
          proceeds from issuance of senior convertible notes
        		                          
          proceeds received in satisfaction of stock subscription receivable
        		                          
          transaction costs incurred on senior convertible notes
        		                          
          payment of placement agent and legal fees associated with clinical funding commitment
        		        0                  
          amortization of right-of-use assets
        		    18,730 18,335 17,947                    
          deferred income tax benefit
        		    -141,251 -170,602 -130,299                    
          payments made by an investor in satisfaction of their stock subscription receivable
        		                          
          prepaid expenses
        		    47,642 -20,722 10,632                    
          due (from)/to related parties
        		    23,728                      
          payments made directly to our contract research organization for clinical trial expenses by an investor in partial satisfaction of their stock subscription receivable
        		                          
          proceeds from (purchase of) certificates of deposit
        		                          
          payments made directly to our contract research organization by an investor in partial satisfaction of their stock subscription receivable
        		      115,000                    
          current portion of operating lease liability
        		      -19,276                    
          net decrease in cash
        		      -492,429                    
          non-cash investing and financing activities:
        		                          
          reduction in deferred lease liability
        		      -9,963                    
          recognize the exclusive license intangible asset acquired from concert
        		                          
          recognize deferred tax liability for basis difference of intangible asset
        		                          
          recognize additional paid-in-capital for consideration paid from the transfer of 2,090,301 common shares of processa released by promet to concert for processa
        		                          
          impairment of software costs
        		                          
          vendor deposit
        		                          
          due to related parties
        		                          
          accrued rent liability
        		                          
          accrued liabilities
        		       -264,292 202,317                  
          proceeds from the redemption of certificates of deposit
        		                          
          acquisition costs related to the concert intangible asset
        		                          
          cash received in a reverse acquisition transaction
        		                          
          proceeds from issuance of common stock, net of issuance costs of 308,830
        		                          
          costs related to the clinical trial funding commitment
        		                          
          costs related to the conversion of the senior notes and in 2017, payment of debt issuance costs
        		                          
          cash and cash equivalents – beginning of year
        		                          
          cash and cash equivalents – end of year
        		                          
          proceeds from certificates of deposit
        		                          
          acquisition of intangible asset
        		        0                  
          payment of debt issuance costs
        		                          
          transaction costs incurred in connection with the conversion of senior convertible notes
        		                          
          cash and cash equivalents
        		                          
          beginning of period
        		        0                  
          end of period
        		        -426,230                  
          non-cash financing and investing activities
        		                          
          recognize exclusive license intangible asset acquired from concert
        		        0                  
          recognize deferred tax liability for basis difference for intangible asset
        		        0                  
          recognize additional paid-in capital for consideration paid from the transfer of 2,090,301 common shares of processa owned by promet to concert
        		        0                  
          cash paid for intangible asset acquired from concert
        		                          
          conversion of 2,350,000 of senior convertible debt and related accrued interest into 1,206,245 shares of common stock and warrants
        		        0                  
          common stock and stock purchase warrants issued in connection with a clinical trial funding commitment
        		        0                  
          accrued interest on investments
        		                          
          note receivable related to the sale of common stock and stock purchase warrants
        		                          
          security deposit
        		                          
          proceeds from issuance of common stock
        		                          
          cash and cash equivalents - beg. of year
        		                          
          cash flows from operating activities:
        		                          
          less loss from discontinued operations, net of tax
        		                          
          loss from continuing operations
        		         -322,891 -118,478 -75,627 -90,807 -68,291 -46,460 -131,621           
          adjustments to reconcile net loss to cash flows from operating activities:
        		                          
          depreciation expense
        		            0 0 0 159 -21,101 23,635 28,628 29,089       
          gain on debt forgiveness
        		         -36,359 -30,912  20,424 0             
          amortization of discount on note payable
        		            0 0 0 967 14,821 14,821 14,660 14,499       
          changes in current assets and liabilities:
        		                          
          decrease in prepaid and other current assets
        		             0 1,269 46,453  26,531 9,927 89,434       
          increase in accounts payable
        		         -34,238 -44,066  -24,918 -3,254   4,761 -28,065   45,609 32,596 29,274 -23,080 -24,366 -131,887 
          (decrease) in income taxes payable
        		         -200                 
          (decrease) in accrued liabilities
        		         -28,227 -8,188   1             
          increase in interest payable
        		         40,903 30,467 15,150 15,485 -50,761 38,990 50,899 54,818 52,989 37,104 8,877       
          increase in interest payable, related party
        		         131,037 94,889 46,796 47,836 114,083             
          net cash from operating activities from continuing operations
        		         -249,975 -76,288 -1,598 -3,455 16,778 -276 -43,900           
          net cash from operating activities from discontinued operations
        		            -3,542 -42 -2,297 -6,469           
          cash flows from investing activities:
        		                          
          proceeds from sale of assets held for sale
        		             -25,000 15,000 27,000           
          net cash from investing activities from continuing operations
        		            0 -25,000 15,000 27,000           
          cash flows from financing activities:
        		                          
          proceeds from issuance of senior secured notes payable
        		         327,000 75,000  0 0 0 15,000 0 39,000 264,000 450,000     0 9,913 
          net cash from financing activities from continuing operations
        		         327,000 75,000  0 0 0 15,000           
          net change in cash and cash equivalents
        		         77,025 -1,288 -1,598 -6,997 -8,264 12,427 -8,369 -4,467 -96 -26,590 20,549 -34,500 15,835 -42,349 -104,616 -809,073 372,133 
          cash and cash equivalents, beginning of period
        		         3,237        0 0 21,234 0 0 0 186,864 -6,000 0 
          cash and cash equivalents, end of period
        		         80,262        -96 -26,590 41,783 -34,500 15,835 -42,349 82,248 -815,073 372,133 
          less: loss from discontinued operations, net of tax
        		            17 42 -3,260 2,004           
          (increase) in receivables
        		                          
          cash and cash equivalents, beginning of period, including discontinued operations
        		          3,237 3,237 0 0 0 14,440           
          cash and cash equivalents, continuing operations, end of period
        		          1,949 1,639 -3,455 -8,222 12,475 2,439           
          cash and cash equivalents, discontinued operations, end of period
        		             -42 -48 3,632           
          increase in receivables
        		               -25,000  97,365 -12,459 -87,269       
          decrease in accounts payable
        		           13,157    10,021    -12,516       
          decrease in accrued liabilities
        		           -1,074    -840 -5,183 17,854 -19,082 -35,363  -78,365     
          operating activities:
        		                          
          adjustments to reconcile net loss from continuing operations to net cash from operating activities:
        		                          
          amortization of intangible assets
        		                0 0 89,286 89,285       
          impairment of assets held for sale
        		                101,069          
          loss on disposal of equipment
        		                9,238 44,128         
          bad debt expense
        		                0          
          shares exchanged for services
        		                          
          decrease in receivables
        		                    22,644   -1,145 5,199  
          decrease in prepaid expenses and other current assets
        		                          
          increase in inventory
        		                12,314    -21,267 5,526 57,503 -119,236 60,883 -8,629 
          increase in income taxes payable
        		                25 25 25 25     25 25 
          increase in accrued liabilities
        		                       -145,158 42,619 23,554 
          increase in deferred revenue
        		                  22,500 84,964       
          investing activities:
        		                          
          purchases of property and equipment
        		                0 0 0 -1,399 -22,580 -9,947 -2,000 -13,772 83,506 -103,848 
          proceeds from the sale of assets held for sale
        		                          
          proceeds from the sale of property and equipment
        		                          
          net cash from investing activities from discontinued operations
        		                          
          financing activities:
        		                          
          proceeds from issuance of common shares with warrants
        		                          
          repayment on equipment loan payable
        		                0 8,130 -14,068 -13,964       
          net cash from financing activities from discontinued operations
        		                          
          (increase) in other receivables
        		                          
          (increase) in inventory
        		                          
          (increase) in consigned inventory
        		                          
          (decrease) in deferred revenue
        		                          
          proceeds from issuance of common shares
        		                  0 88,000       
          non-cash expenses exchanged for services
        		                  0 25,500       
          decrease in inventory
        		                  -1,901 24,889       
          increase in consigned inventory
        		                 85,485 0 -124,448       
          loss on extinguishment of debt
        		                          
          impairment of goodwill
        		                    0 0 0 390,659   
          proceeds from sale of property and equipment
        		                          
          proceeds from issuance of unsecured notes payable
        		                    95,000 579,003 570,000 1,000,000   
          repayment of senior subordinated note payable
        		                          
          proceeds from issuance of series d preferred shares
        		                          
          shares issued for consulting
        		                          
          decrease in deferred revenue
        		                          
          cash from operating activities
        		                 -47,226 -276,522 -502,088 -459,383 -540,239 -708,088 -987,738 -462,538 -709,324 
          acquisition of business
        		                          
          cash from investing activities
        		                 0 0 -1,399 -22,580 -9,947 -2,000 -10,417 83,506 -103,848 
          proceeds from issuance of common shares and warrants
        		                          
          cash from financing activities
        		                 47,130 249,932 524,036 447,463 566,021 667,739 893,539 -430,041 1,185,305 
          cash flows from investing activites:
        		                          
          increase in prepaid and other current assets
        		                    -14,516   -7,056 5,706 -31,632 
          proceeds from advance payment
        		                          
          repayment of senior secured notes payable
        		                        0  
          adjustments to reconcile net loss to cash from operating activities:
        		                          
          amortization of discount on notes payable
        		                     58,344 51,271 21,086   
          cash from acquisition of subsidiary
        		                     0 0 3,355   
          loan repayment of senior subordinated note payable
        		                     0 -250,000 -250,000   
          proceeds from issuance of preferred shares, net of commissions paid
        		                     0 355,967 153,996   
          repayment of loan payable
        		                     -12,982 -8,228 -10,457   
          stock-based compensation and other non-cash expenses
        		                      34,313 129,408   
          proceeds from issuance of senior subordinated note payable
        		                          
          proceeds from exercise of options
        		                          
          proceeds from loan payable
        		                          
          amortization expense
        		                          
          proceeds from exercise of stock options
        		                          
          proceeds from issuance of series a preferred shares
        		                          
          proceeds from issuance of series b preferred shares
        		                          
          proceeds from issuance of series c preferred shares
        		                          
          loan proceeds from equipment loan payable
        		                          
          amortization
        		                         89,286 
          proceeds from issuance of series d preferred shares, net of commissions paid
        		                          
          loan repayment of equipment loan payable
        		                          
          dividend payable in accrued expenses